MedTrace Logo

Mucosal Pressure of the Laryngeal Mask Airway Supreme Versus the i-Gel in Paralyzed Anesthetized Female Patients

NCT01367678 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-08-24

No results posted yet for this study

Summary

In the following randomized non-crossover study, the investigators test the hypothesis that directly measured mucosal pressure differ between the laryngeal mask airway (LMA) Supreme and the i-Gel in paralyzed anesthetized females.

Thirty females aged 19-65 years were randomly allocated to receive either the size 4 LMA Supreme or i-Gel for airway management. Microchip sensors were attached to the LMA Supreme/i-Gel at four locations corresponding to the A, base of tongue; B, distal oropharynx; C, hypopharynx; and D, pyriform fossa.

Insertion success rate and oropharyngeal leak pressure were also measured.

Conditions

  • Device Induced Injury
  • Necrosis, Pressure
  • Complication of Device Insertion
  • Airway Morbidity

Interventions

DEVICE

Laryngeal Mask Airway Supreme

Directly measured mucosal pressures

DEVICE

i-Gel extraglottic airway device

Directly measured mucosal pressures

Sponsors & Collaborators

  • Medical University Innsbruck

    collaborator OTHER

  • Schulthess Klinik

    lead OTHER

Principal Investigators

  • Christian Keller, MD, M.Sc. · Schulthess Klinik

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Austria
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01367678 on ClinicalTrials.gov